These alterations were ameliorated by insulin treatment, suggesting that both insulin deficiency and hyperglycemia significantly influence keratinocyte differentiation and proliferation, potentially representing a primary mechanism underlying epidermal barrier impairment in patients with diabetes (28). This evidence concerns the gene INS and diabetes mellitus.